San Francisco, CA Genedata, a leading provider of advanced software solutions for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics, a clinical-stage biotechnology company, has adopted Genedata as their preferred bioinformatics solution provider. Aptevo will use the Genedata Biologics® platform to facilitate expansion of their pipeline of novel bispecific antibody candidates focused on immuno-oncology, autoimmune disease and inflammation. […]

Supporting personalized treatment options and providing tools to reduce healthcare expenditures BC Platforms, a world leader in genomic data management and analytics, today announces that it has signed a co-operation agreement with Negen to use its platform to provide detailed insights into raw genomic data for clinical reporting capabilities. Both companies work in the front line of […]

Powerful, flexible and easy-to-use analysis solution gets the most out of NGS data Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of the eagerly-anticipated update to its SureSeq™ Interpret software, included with purchases of SureSeq NGS panels. Designed to help researchers effortlessly translate cumbersome NGS data into meaningful results, OGT has […]

Modeling and simulation’s positive impact on NDA and BLA approvals through July 1, 2018 has included first use, orphan and priority review drugs for multiple indications PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today reported that 95% of novel new drug approvals by the […]

Covaris and Bioz Have Partnered to Bring Data and Transparency to the Customer Experience    LOS ALTOS, CA – Bioz, Inc., a Silicon Valley AI data company, is proud to announce a new partnership with Covaris, Inc., the gold standard of DNA fragmentation in Next Generation Sequencing. By combining the latest advances in Natural Language Processing […]

Biomedical research faces enormous challenges as the volume of genomic, transcriptomic, metabolomic, phenotypic, and other data generated in research labs across the world continues to grow. According to the National Center for Biotechnology Information, the total amount of sequence data alone is doubling every seven months. Although analyzing this staggering amount of data presents the potential […]

Streamlines genome interpretation to improve the utility of genomic data Illumina, Inc. announces the release of open source, novel artificial intelligence (AI) software that can distinguish between potential disease-causing mutations, and the millions of benign genetic variants in individuals. The new AI software for genome interpretation has been publicly released through Illumina’s BaseSpace Sequence Hub and GitHub. […]

Researchers to access list of novel targets for Alzheimer’s disease treatment SEATTLE–Sage Bionetworks announces the launch of the Agora platform (agora.ampadportal.org) an interactive, web-based tool that allows researchers to explore curated genomic analyses of Alzheimer’s Disease (AD), including a list of early candidate target nominations for AD. The analyses accessible through Agora represent the culmination of over […]

Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has entered into a one-year funded research collaboration with a large European consortium to further develop and validate the mechanistic Transdermal Compartmental Absorption and Transit (TCAT™) model in GastroPlus™. Dr. […]

London – Lifebit, the startup building a fully-automated system that generates and processes genomics data in real time at scale, today announces that it has closed a $3m (£2.25m) Seed funding round led by Pentech and Connect Ventures, with participation from Beacon Capital and Tiny VC (AngelList). The company is simultaneously announcing the launch of […]